Related Experiment Video
Updated: Sep 25, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Differences of inflammatory cytokine profile in patients with vulnerable plaque: A coronary CTA study
Caroline Roesner1, Markus Goeller1, Dorette Raaz-Schrauder1
1Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Cardiology, Erlangen, Germany.
Insights
Inflammatory biomarkers like IL-1a and IL-17 are linked to coronary plaque volume and vulnerable plaque. Monocyte chemoattractant protein-1 (MCP-1) may offer protective effects against atherosclerosis progression.
Area of Science:
- Cardiovascular disease research
- Inflammation and immunology
- Biomarker discovery
Background:
- Atherosclerosis involves various pro- and anti-inflammatory biomarkers.
- Understanding these biomarkers' association with coronary plaque is crucial.
Purpose of the Study:
- To analyze the association between different biomarkers and coronary plaque volume.
- To investigate the link between biomarkers and vulnerable plaque subcomponents.
Main Methods:
- Coronary CT angiography (CTA) was performed on 301 patients.
- Semi-automated software quantified total plaque volume (TPV) and non-calcified plaque volume (NCPV).
- Serum cytokine levels were analyzed and correlated with plaque characteristics.
Main Results:
- High plaque burden correlated with increased levels of IFNƔ, IL-1a, IL-2, IL-4, IL-10, IL-17 and decreased levels of IL-8, MCP-1.
- Multivariable analysis identified IL-1a and Eotaxin as positively associated with vulnerable plaque, while MCP-1 showed an inverse association.
- Elevated IL-17 levels were observed in patients with high vulnerable plaque burden.
Conclusions:
- Cytokine profiles differ significantly based on coronary plaque volume.
- IL-1a and IL-17 may promote atherosclerosis, while MCP-1 might have protective effects.
- Further longitudinal studies are needed to explore therapeutic targets.
Background And Aims:
Various pro- and anti-inflammatory biomarkers are involved in the process of atherosclerosis. We analyzed the association of different biomarkers with coronary plaque volume and vulnerable plaque subcomponents.
Methods:
In 301 patients undergoing coronary CT angiography (CTA), total coronary plaque volume (TPV) and subcomponents including non-calcified plaque volume (NCPV) and vulnerable plaque burden were quantified using semi-automated software. Serum was analyzed for various cytokines.
Results:
Out of 301 patients, 207 (69%) were male. The mean age was 59 ± 10 years. Patients were divided using the median of TPV, NCPV and vulnerable plaque burden. In univariable analysis, patients with high TPV, high NCPV and high vulnerable plaque burden showed significant higher serum levels for IFNƔ, IL-1a, -2, -4, -10 and -17 and significant lower levels for IL-8 and MCP-1 (all p < 0.05). Multivariable analysis showed positive associations between high vulnerable plaque burden, IL-1a (OR 2.60, p = 0.001) and Eotaxin (OR 1.89, p = 0.020), and inverse association to MCP-1 (OR 0.33, p < 0.001), independent of age, gender and CVRF. In exploratory subanalyses, patients with presence of atherosclerosis (n = 247; 82%) showed significantly higher levels of IL-17 in all subgroups with high vulnerable plaque burden, irrespective of overall plaque volume (all p < 0.001).
Conclusions:
The cytokine profile significantly differs between patients with high and low coronary plaque volume. IL-1a and IL-17 seem to play a major proatherogenic role in vulnerable plaque formation, whereas MCP-1 paradoxically portends protective effects. Longitudinal studies with serial cytokine testing are needed to identify potential targets for therapeutic interventions.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

